[ Pobierz całość w formacie PDF ]
.van Ameringen M., Mancini C., Wilson C.(1996) Buspirone augmentation ofselective serotonin reuptake inhibitors (SSRIs) in social phobia.J.Affect.Dis.,39: 115 121.94.Bell J., DeVeaugh-Geiss J.(1994) Multicenter trial of a 5-HT3 antagonist,ondansetron, in social phobia.Presented at the 33rd Annual Meeting of theAmerican College of Neuropsychopharmacology, San Juan, 12 16 December.95.Pande A.C., Davidson J.R., Jefferson J.W., Janney C.A., Katzelnick D.J.,Weisler R.H., Greist J.H., Sutherland S.M.(1999) Treatment of social phobiawith gabapentin: a placebo-controlled study.J.Clin.Psychopharmacol., 19: 341348.96.Barnett S.D., Kramer M.L., Casat C.D., Connor K.M., Davidson J.R.(2002)Efficacy of olanzapine in social anxiety disorder: a pilot study.J.Psycho-pharmacol., 16: 365 368.97.Pallanti S., Quercioli L., Rossi A., Pazzagli A.(1999) The emergence of socialphobia during clozapine treatment and its response to fluoxetine augmenta-tion.J.Clin.Psychiatry, 60: 819 823.98.Gorman J.M., Liebowitz M.R., Fyer A.J., Campeas R., Klein D.F.(1985)Treatment of social phobia with atenolol.J.Clin.Psychopharmacol., 5: 298 301.99.Turner S., Beidel D.C., Jacob R.G.(1994) Social phobia: a comparison ofbehaviour therapy and atenolol.J.Consult.Clin.Psychol., 62: 350 358.100.Falloon I.R., Llody G.G., Harpin R.E.(1981) The treatment of social phobia.Real-life rehearsal with nonprofessional therapists.J.Nerv.Ment.Dis., 169:180 184.101.Brantigan C.O., Brantigan T.A., Joseph N.(1982) Effects of beta-blockade andbeta-stimulation on stage fright.Am.J.Med., 72: 88 94.102.Drew P.J.T, Barnes J.N., Evans S.J.W.(1983) The effects of acute B-adrenoceptor blockade on examination performance.Br.J.Psychiatry, 19:782 786.103.Gates G.A., Saegert J., Wilson N., Johnson L., Shepard A., Hearne E.M.(1985)Effect of beta-blockage on singing performance.Ann.Otol.Rhinol.Laryngol.,94: 570 574.104.Hartley L.R., Ungapen S., Davie I., Spencer D.J.(1983) The effect of betaadrenergic blockade on speaker s performance and memory.Br.J.Psychiatry,142: 512 517.105.James I.M., Griffith D.N.W, Pearson R.M., Newby P.(1977) Effect ofoxprenolol on stage-fright in musicians.Lancet, ii: 952 954. 140 __________________________________________________________________________________________ PHOBIAS106.Siitonen L., Janne J.(1976) Effect of beta-blockade during bowling competi-tion.Ann.Clin.Res., 8: 393 398.107.Liden S., Gottfries C.G.(1974) Beta-blocking agents in the treatment ofcatecholamine-induced symptoms in musicians.Lancet, 2: 529.108.Neftel K.A., Adler R.H., Kappeli L., Rossi M., Kaser H.E., Bruggesser H.H.,Vorkauf H.(1982) Stage fright in musicians: a model illustrating the effect ofbeta blockers.Psychosom.Med., 44: 461 469.109.James I.M., Burgoyne W., Savage I.T.(1983) Effect of pindolol on stress-relateddisturbances of musical performance: preliminary communication.J.Roy.Soc.Med., 76: 194 196.110.Schneier F.R.(1995) Clinical assessment strategies for social phobia.Psychiatr.Ann., 25: 550 553.111.Goldstein S.(1987) Treatment of social phobia with clonidine.Biol.Psychiatry,22: 369 372.112.Davidson J.R., Foa E.B., Connor K.M., Churchill L.E.(2002) Hyperhidrosis insocial phobia.Prog.Neuropsychopharmacol.Biol.Psychiatry, 26: 1327 1331.113.Stein M.B., Sareen J., Hami S., Chao J.(2001) Pindolol potentiation ofparoxetine for generalized social phobia: a double-blind, placebo-controlled,crossover study.Am.J.Psychiatry, 158: 1725 1727.114.Klein D.F., Fink M.(1962) Psychiatric reaction patterns to imipramine.Am.J.Psychiatry, 119: 432 438.115.West E.D., Dally P.J.(1959) Effects of iproniazid in depressive syndromes.Br.Med.J., 1: 1491 1494.116.Sargant W., Dally P.(1962) Treatment of anxiety states by antidepressantdrugs.Br.Med.J., 1: 6 9.117.Klein D.F.(1964) Delineation of two drug-responsive anxiety syndromes.Psychopharmacologia, 5: 397 408.118.Lipsedge M.S., Hajioff J., Huggins P., Napier L., Pearce J., Pike D.J., Rich M.(1973) The management of severe agoraphobia: a comparison of iproniazidand systematic desensitization.Psychopharmacologia, 32: 67 80.119.Sheehan D.V., Ballenger J., Jacobsen G.(1980) Treatment of endogenousanxiety with phobic, hysterical, and hypochondriacal symptoms.Arch.Gen.Psychiatry, 37: 51 59.120.Zitrin C.M., Klein D.F., Woerner M.G.(1980) Treatment of agoraphobia withgroup exposure in vivo and imipramine.Arch.Gen.Psychiatry, 37: 63 72.121.Ballenger J.C., Davidson J.R.T, Lecrubier Y., Nutt D.J., Bobes J., Beidel D.C.,Ono Y., Westenberg H.G.(1998) Consensus statement on panic disorder fromthe International Consensus Group on Depression and Anxiety.J.Clin.Psychiatry, 59 (Suppl.8): 47 54.122.Pande A.C., Pollack M.H., Crockatt J., Greiner M., Chouinard G., Lydiard R.B.,Taylor C.B., Dager S.R., Shiovitz T.(2000) Placebo-controlled study ofgabapentin treatment of panic disorder.J.Clin.Psychopharmacol., 20: 467 471.123.Boyer W.(1995) Serotonin uptake inhibitors are superior to imipramine andalprazolam in alleviating panic attacks: a meta-analysis.Int.Clin.Psycho-pharmacol., 10: 45 49.124.Evans L., Kenardy J., Schneider P., Hoey H.(1986) Effect of a selectiveserotonin reuptake inhibitor in agoraphobia with panic attacks: a double-blindcomparison of zimeldine, imipramine and placebo.Acta Psychiatr.Scand., 73:49 53.125.Otto M.W., Tuby K.S., Gould R.A., McLean R.Y., Pollack M.H.(2001) Aneffect size analysis of the relative efficacy and tolerability of serotonin PHARMACOTHERAPY OF PHOBIAS: A REVIEW _______________________________________ 141selective reuptake inhibitors for panic disorder.Am.J.Psychiatry, 158: 19891992.126.Mavissakalian M.R., Perel J.M.(1995) Imipramine treatment of panic disorderwith agoraphobia: dose ranging and plasma level-response relationships.Am.J.Psychiatry, 152: 673 682.127.Gloger S., Grunhaus L., Gladic D., O Ryan F., Cohen L., Codner S.(1989) Panicattacks and agoraphobia: low dose clomipramine treatment.J.Clin.Psychopharmacol., 9: 28 32.128.Lesser I.M., Lydiard R.B., Antal E., Rubin R.T., Ballenger J.C., DuPont R.(1992) Alprazolam plasma concentrations and treatment response in panicdisorder and agoraphobia.Am.J.Psychiatry, 142: 1556 1662.129.Wardle J., Hayward P., Higgitt A., Stabl M., Blizard R., Gray J.(1994) Effects ofconcurrent diazepam treatment on the outcome of exposure therapy inagoraphobia.Behav.Res.Ther., 32: 203 215.130.Le Doux J.(1998) Fear and the brain: where have we been, and where are wegoing? Biol.Psychiatry, 44: 1229 1238.131.Abene M.V., Hamilton J.D.(1998) Resolution of fear of flying with fluoxetinetreatment.J.Anxiety Disord., 12: 599 603.132.Benjamin J., Ben-Zion I.Z., Karbofsky E., Dannon P.(2000) Double-blindplacebo-controlled pilot study of paroxetine for specific phobia.Psycho-pharmacology, 149: 194 196.133.Mawson A.B.(1970) Methohexitone-assisted desensitisation in treatment ofphobias.Lancet, i: 1084 1086.134.Bernadt M.W., Silverstone T., Singleton W.(1980) Behavioral and subjectiveeffects of beta-adrenergic blockade in phobic subjects.Br.J.Psychiatry, 137:452 457.135.Sartory G., MacDonald R., Gray J.A
[ Pobierz całość w formacie PDF ]